EZElisa™人过氧化物酶体激活受体δ（PPARd）ELI
SA试剂盒-EZElisa™ Human Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit- 询价
- Biogradetech
- 美国
- A-QEK03444-96wells
- 2025年07月14日
企业认证
相关产品推荐更多 >
EZElisa ™ Vestigial Like Protein 1（VGLL 1）试剂盒-EZElisa™ Vestigial Like Protein 1 (VGLL1) Kit
询价
EZElisa™分泌成分（SC）ELISA试剂盒-EZElisa™ secretory component (SC) ELISA Kit
询价EZElisa™人超敏生长激素（us-GH）ELISA试剂盒-EZElisa™ Human Ultra Sensitive Growth hormone (us-GH) ELISA Kit
询价EZElisa™大鼠补体C1q肿瘤坏死因子相关蛋白15（CTRP15）ELISA试剂盒-EZElisa™ Rat Complement C1q tumor necrosis factor-related protein 15 (CTRP15) ELISA Kit
询价
EZElisa™羊白细胞介素23（IL-23）ELISA试剂盒-EZElisa™ Sheep Interleukin 23 (IL-23) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Human Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™人过氧化物酶体激活受体δ（PPARd）ELISA试剂盒，EZElisa™ Human Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit，过氧化物酶体激活受体δ（PPARd）ELISA试剂盒, Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit
产品名称：EZElisa™人过氧化物酶体激活受体β（PPAR-beta）ELISA试剂盒-EZElisa™ Human Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit
产品货号：A-QEK03444-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of Peroxisome Proliferator Activated Receptor Delta (PPARd) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：0.312 - 20 ng/ml
该EZElisa™人过氧化物酶体激活受体δ（PPARd）ELISA试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™人过氧化物酶体激活受体β（PPAR-beta）ELISA试剂盒-EZElisa™ Human Peroxisome Proliferator Activated Receptor Delta (PPARd) ELISA Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
. Peroxisome proliferator-activated receptor beta/ delta (PPARβ/δ), one of the nuclear hormone ligand-dependent transcription factors, has recently been reported to be involved in tumorigeniCity. We have shown that NSCLC cells express PPARβ/δ protein
. A new drug candidate belonging to the family of the peroxisome proliferator-activated receptor-delta agonists termed GW1516 (also referred to as GW501516) has been prohibited by the World Anti-Doping Agency in 2009
. Then we elaborate on the protocol of efficient induction for adipogenic differentiation and adipocyte-specific gene expression, including peroxisome proliferator-activated receptor-γ, with our culture system in human MPCs.
技术资料暂无技术资料 索取技术资料
